Severe Hypoxemia With Normal Heart and Respiratory Rate in Early-stage Coronavirus Disease 2019 Patients: The "Happy Hypoxemia Phenomenon".
作者信息
Safe Izabella Picinin, Lacerda Marcus Vinícius Guimarães, Almeida Val Fernando Fonseca, Sampaio Vanderson Souza, Hajjar Ludhmila Abrahão, Brito-Sousa Jose Diego, Baía-da-Silva Djane, Bassat Quique, Landoni Giovanni, Monteiro Wuelton Marcelo
机构信息
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.
Universidade do Estado do Amazonas, Manaus, Brazil.
出版信息
Clin Infect Dis. 2021 Aug 2;73(3):e856-e858. doi: 10.1093/cid/ciab026.
Abstract
摘要
相似文献
1
Severe Hypoxemia With Normal Heart and Respiratory Rate in Early-stage Coronavirus Disease 2019 Patients: The "Happy Hypoxemia Phenomenon".
Clin Infect Dis. 2021 Aug 2;73(3):e856-e858. doi: 10.1093/cid/ciab026.
2
Happy hypoxemia, or blunted ventilation?
Respir Res. 2021 Jan 6;22(1):4. doi: 10.1186/s12931-020-01604-9.
3
[Pathophysiology of COVID-19 related happy hypoxemia].
Rev Med Suisse. 2021 Apr 28;17(736):831-834.
4
Silent or 'Happy' Hypoxemia: An Urgent Dilemma for COVID-19 Patient Care.
MEDICC Rev. 2020 Oct;22(4):85-86. doi: 10.37757/MR2020.V22.N4.9.
5
Respiratory Drive, Dyspnea, and Silent Hypoxemia: A Physiological Review in the Context of COVID-19.
Respir Care. 2022 Oct;67(10):1343-1360. doi: 10.4187/respcare.10075. Epub 2022 May 2.
6
Silent Hypoxemia in COVID-19 Pneumonia.
Adv Exp Med Biol. 2022;1395:117-122. doi: 10.1007/978-3-031-14190-4_20.
7
Silent Hypoxia in COVID-19 Pneumonia: State of Knowledge, Pathophysiology, Mechanisms, and Management.
AACN Adv Crit Care. 2022 Jun 15;33(2):143-153. doi: 10.4037/aacnacc2022448.
8
Happy Hypoxemia in COVID-19-A Neural Hypothesis.
ACS Chem Neurosci. 2020 Jul 1;11(13):1865-1867. doi: 10.1021/acschemneuro.0c00318. Epub 2020 Jun 12.
9
Silent Hypoxia in COVID-19: A Case Series.
Respiration. 2022;101(4):376-380. doi: 10.1159/000520083. Epub 2021 Nov 26.
10
Risk factors associated with asymptomatic hypoxemia among COVID-19 patients: a retrospective study using the nationwide Japanese registry, COVIREGI-JP.
J Infect Public Health. 2022 Mar;15(3):312-314. doi: 10.1016/j.jiph.2022.01.014. Epub 2022 Jan 31.
引用本文的文献
1
Dosage and utilization of dexamethasone in the management of COVID-19: A critical review.
World J Virol. 2024 Sep 25;13(3):95709. doi: 10.5501/wjv.v13.i3.95709.
2
Assistance time and peripheral oxygen saturation in prehospital emergency data as predictors of COVID19 hospital outcomes.
Sci Rep. 2024 Sep 6;14(1):20775. doi: 10.1038/s41598-024-71290-w.
3
Silent hypoxia is not an identifiable characteristic in patients with COVID-19 infection.
Respir Med. 2022 Jun;197:106858. doi: 10.1016/j.rmed.2022.106858. Epub 2022 Apr 26.
4
Intubation Timing in COVID-19 Based on ROX Index and Association With Patient Outcomes.
Respir Care. 2022 Oct;67(10):1291-1299. doi: 10.4187/respcare.09937. Epub 2022 Mar 17.
Zotero 插件